Analyst ratings and price targets can significantly influence investor sentiment and stock price. The reiteration of a 'Buy' rating and an $8 price target by HC Wainwright & Co. indicates their positive outlook on Puma Biotechnology, which could lead to increased investor confidence and a potential rise in the stock's price in the short term.